Immediate Impact
74 standout
Citing Papers
Digital empowerment and win-win co-operation for green and low-carbon industrial development: Analysis of regional differences based on GMM-ANN intelligence models
2024 Standout
FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine
2024 Standout
Works of Öner Tulum being referenced
Sick with “shareholder value”: US pharma’s financialized business model during the pandemic
2023
US biopharmaceutical finance and the sustainability of the biotech business model
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Öner Tulum | 216 | 43 | 85 | 75 | 14 | 353 | |
| Josh Siepel | 160 | 25 | 101 | 82 | 18 | 338 | |
| Giorgio Ricchiuti | 271 | 18 | 51 | 99 | 29 | 349 | |
| Carmine Ornaghi | 276 | 10 | 63 | 107 | 22 | 387 | |
| John Jewkes | 212 | 8 | 35 | 86 | 19 | 410 | |
| A. Mina | 195 | 15 | 125 | 120 | 7 | 384 | |
| Susanne Thorwarth | 246 | 6 | 42 | 137 | 13 | 382 | |
| Fabienne Orsi | 166 | 37 | 41 | 63 | 19 | 338 | |
| Hyeog Ug Kwon | 241 | 3 | 100 | 77 | 22 | 330 | |
| Mattias Ganslandt | 277 | 10 | 32 | 50 | 19 | 327 | |
| Linda A. Hall | 185 | 26 | 71 | 196 | 13 | 353 |
All Works
Login with ORCID to disown or claim papers
Loading papers...